BioSpace News Archive

The Menarini Group and Radius Health, Inc. (Nasdaq: RDUS) announced today that the companies have entered into an exclusive global license agreement for development and commercialization of elacestrant.

Jamieson Wellness Inc. (“Jamieson Wellness” or the “Company”) (TSX:JWEL) announced today that the Company will release its second quarter 2020 financial results after the market close on Wednesday, August 12, 2020. The Company will host a conference call for investors at 5:00 p.m. Eastern Time to discuss the second quarter 2020 results. The call can be accessed live over the telephone by dialing 1-800-437-2398 from Canada a

Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $1.60 per share dividend for the third quarter of 2020. The dividend will be paid on September 8, 2020 , to all stockholders of record as of the close of business on August 17, 2020 . About Amgen Amgen is committed to unlocking the potential

Edwards Lifesciences Corporation, the global leader in patient-focused innovations for structural heart disease and critical care monitoring, reported financial results for the quarter ended June 30, 2020.

The Board of Directors of PerkinElmer, Inc., declared a regular quarterly dividend of $0.07 per share of common stock July 23, 2020.

Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) announced today that Strul Medical Group LLC (“SMG”) exercised 1,424,049 of the 2,573,959 common share purchase warrants (the “May Warrants”) issued pursuant to a Securities Purchase Agreement dated May 26, 2020 at an exercise price of US$2.634 per May Warrant

miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that the Food & Drug Administration (FDA) has granted orphan drug designation to cobomarsen, for the treatment of T-cell lymphoma.

Plus Therapeutics, Inc. (Nasdaq: PSTV ) (the “Company”) today announced that it will be presenting at the YAFO ACCESS CHINA - 2020 Summer Online Partnering Day on Thursday, July 30 at 10:00 pm EST. Dr. Marc Hedrick, President and CEO of Plus Therapeutics, will be hosting the presentation and answering questions from investors. To access the live presentation, please use the following information: YAFO ACCESS CHINA Partnering Conference

- Amgen (NASDAQ:AMGN) today announced that it will report its second quarter financial results on Tuesday, July 28, 2020 , after the close of the U.S. financial markets. The announcement will be followed by a conference call with the investment community at 2:00 p.m. PT . Participating in the call from Amgen will be Robert A.

Maxar Technologies (NYSE:MAXR) (TSX:MAXR), a trusted partner and innovator in Earth Intelligence and Space Infrastructure, plans to release its second quarter 2020 financial results after the market closes on Wednesday, August 5, 2020. Maxar President and Chief Executive Officer, Dan Jablonsky, and Executive Vice President and Chief Financial Officer, Biggs Porter, will host an earnings conference call the same d